articles and announcements

Latest News

March 1, 2012

Collaborative Research Partnership Announcement

New Angelman Research Collaborative Partnership Announcement The Canadian Angelman Syndrome Society (CASS) and Angelman Syndrome Foundation (ASF) today formally announce a collaborative research partnership to fund the Expert Panel on Challenging and Difficult to Treat Behaviors in Angelman Syndrome (AS). […]

Read more
February 28, 2012

Over $1 Million Invested in Angelman Syndrome Research

Angelman Syndrome Foundation Funds More Than $1 Million in Research Grants for 2009 The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than […]

Read more
May 23, 2011

Natural History Study and Drug Trial of Levodopa

Natural History Study and Drug Trial of Levodopa at Boston Children’s Hospital Angelman syndrome (AS) is a rare, neurogenetic condition characterized by severe developmental delay, movement disorder, speech impairment (often with a complete lack of speech) and an unusually happy […]

Read more